Black Rock Inc. Celldex Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,511,924 shares of CLDX stock, worth $150 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,511,924

Previous 3,675,692 22.75%

Holding current value

$150 Million

Previous $146 Million 29.9%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$35.22 - $51.88 $29.5 Million - $43.4 Million	836,232 Added 22.75%	4,511,924 $189 Million
Q4 2023 Feb 13, 2024	BUY	$22.61 - $40.65 $9.58 Million - $17.2 Million	423,738 Added 13.03%	3,675,692 $146 Million
Q3 2023 Nov 13, 2023	BUY	$25.45 - $37.46 $762,660 - $1.12 Million	29,967 Added 0.93%	3,251,954 $89.5 Million
Q2 2023 Aug 11, 2023	SELL	$30.29 - $38.28 $867,838 - $1.1 Million	-28,651 Reduced 0.88%	3,221,987 $109 Million
Q1 2023 May 12, 2023	BUY	$34.78 - $47.43 $901,567 - $1.23 Million	25,922 Added 0.8%	3,250,638 $117 Million

Q4 2022 Feb 13, 2023	BUY	$27.78 - $45.38 $2.62 Million - $4.28 Million	94,303 Added 3.01%	3,224,716 $144 Million
Q3 2022 Nov 14, 2022	SELL	$22.7 - $37.57 $477,971 - $791,073	-21,056 Reduced 0.67%	3,130,413 $88 Million
Q2 2022 Aug 12, 2022	BUY	$20.5 - $37.33 $2.15 Million - $3.91 Million	104,647 Added 3.43%	3,151,469 $85 Million
Q1 2022 May 12, 2022	SELL	$27.64 - $39.32 $1.5 Million - $2.13 Million	-54,208 Reduced 1.75%	3,046,822 $104 Million
Q4 2021 Feb 10, 2022	SELL	$35.68 - $56.27 $1.17 Million - $1.84 Million	-32,740 Reduced 1.04%	3,101,030 $120 Million
Q3 2021 Nov 09, 2021	BUY	$28.95 - $55.99 $12.5 Million - $24.3 Million	433,120 Added 16.04%	3,133,770 $169 Million
Q2 2021 Aug 11, 2021	BUY	$20.71 - $35.37 $55.9 Million - $95.5 Million	2,700,650 New	2,700,650 $90.3 Million

Others Institutions Holding CLDX

# of Institutions

207

Shares Held

61.2M

Call Options Held

291K

Put Options Held

246K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.56B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account